Biomaterials Journal Citation Rate 2026
0142-9612
eISSN 1878-5905
Elsevier BV
GB
Q1 Quartile Top Tier
About Biomaterials
Biomaterials (B) is a peer-reviewed academic journal covering 3D Printing in Biomedical Research and Bone Tissue Engineering Materials, published by Elsevier BV in GB, catalogued under ISSN 0142-9612 (e-ISSN 1878-5905). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 9.73 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4740 USD). OpenAlex records 22,849 works and 2,276,128 citations, with an h-index of 492.
Biomaterials Citation Rate 2026 — In Context
Biomaterials has a 2025 2-Year Citation Rate (OpenAlex) of 9.73, placing it in the Q1 quartile within the 3D Printing in Biomedical Research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Biomaterials operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Biomaterials should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Biomaterials against similar journals in the field, use our journal comparison tool.
Submission Tips for Biomaterials
- Budget $4740 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers 3D Printing in Biomedical Research, Bone Tissue Engineering Materials, Electrospun Nanofibers in Biomedical Applications. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Biomaterials Compares
Compared against 38 journals in the same research areas.
| ISSN (Print) | 0142-9612 |
|---|---|
| ISSN (Online) | 1878-5905 |
| Publisher | Elsevier BV |
| Country | United Kingdom |
| APC / Cost | $4740 USD |
In-depth profile & metrics
Biomaterials is published by Elsevier BV and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4740.
In our subject taxonomy, Biomaterials is classified under 3D Printing in Biomedical Research, Bone Tissue Engineering Materials, Electrospun Nanofibers in Biomedical Applications and Nanoplatforms for cancer theranostics.
Biomaterials is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 9.731.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Biomaterials
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 9.731 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Biomaterials against similar publications in its field:
Related Journals in Your Field
-
Experimental Cell Research Elsevier IF 64.50
-
Advanced Science Wiley IF 56.90
-
ACS Nano American Chemical Society IF 15.06
-
Advanced Drug Delivery Reviews Elsevier BV IF 12.22
-
Journal of Nanobiotechnology BioMed Central IF 11.11
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S163807576
Get weekly updates for 3D Printing in Biomedical Research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.